Business Wire

ERYTECH to Webcast Presentation at the Jefferies Global Healthcare Conference

Del

Regulatory News:

ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that Chief Executive Officer, Gil Beyen, will present at the Jefferies Global Healthcare Conference on Wednesday, June 6, 2018 at The Grand Hyatt, in New York City.

Conference Details:

  • Conference: Jefferies Global Healthcare Conference
  • Date: June 6, 2018
  • Presentation Time: 11:00 AM EDT / 5:00 CET

A live webcast of the presentation will be available online from the investor relations page of the company's corporate website at http://erytech.com/webcast.html and via the below link: http://wsw.com/webcast/jeff113/eryp/

Following, the live webcast, an archive of the presentation will be available on the company website for 30 days, under the “Investors” section at investors.erytech.com.

About ERYTECH and eryaspase (GRASPA®): www.erytech.com

Founded in Lyon, France in 2004, ERYTECH is a clinical-stage biopharmaceutical company developing innovative therapies for rare forms of cancer and orphan diseases. Leveraging its proprietary ERYCAPS platform, which uses a novel technology to encapsulate therapeutic drug substances inside red blood cells, ERYTECH has developed a pipeline of product candidates targeting markets with high unmet medical needs. ERYTECH’s initial focus is on the development of products that target the altered amino acid metabolism of cancer cells, depriving them of nutrients necessary for their survival.

The Company’s lead product, eryaspase, also known under the trade name GRASPA®, consists of an enzyme, L-asparaginase, encapsulated inside donor-derived red blood cells. L-asparaginase depletes asparagine, a naturally occurring amino acid essential for the survival and proliferation of cancer cells. L-asparaginase has been a standard component of multi-agent chemotherapy for the treatment of pediatric acute lymphoblastic leukemia (ALL), but side effects limit treatment compliance, especially in adults and patients with weak performance status.

Eryaspase demonstrated positive efficacy and safety results in various clinical trials in ALL, including in a Phase 2 study in patients over 55 years of age and in a Phase 2/3 trial in relapsed or refractory ALL patients, as well as in pancreatic cancer, where it achieved positive results in a Phase 2b trial of second-line treatment of patients with metastatic pancreatic cancer. ERYTECH is preparing for the launch of a pivotal Phase 3 clinical trial in second line pancreatic cancer and Phase 2 trials in first line pancreatic cancer and triple-negative breast cancer.

ERYTECH produces eryaspase at its own GMP-approved and operational manufacturing site in Lyon (France), and at a site for clinical production in Philadelphia (USA). ERYTECH has entered into licensing and distribution partnership agreements for eryaspase for ALL and AML in Europe with Orphan Europe (Recordati Group), and for ALL in Israel with TEVA, which will market the product under the GRASPA® brand name. The European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) have granted orphan drug designations for eryaspase for the treatment of ALL, AML and pancreatic cancer.

In addition to eryaspase, ERYTECH is developing erymethionase, methionine-γ-lyase encapsulated in red blood cells, to target cancer cells’ amino acid metabolism and induce tumor starvation. ERYTECH is also exploring the use of its ERYCAPS platform for developing cancer immunotherapies (ERYMMUNE) and enzyme replacement therapies (ERYZYME).

ERYTECH is listed on the Nasdaq Global Select Market in the United States (ticker: ERYP) and on the Euronext regulated market in Paris (ISIN code: FR0011471135, ticker: ERYP). ERYTECH is part of the CAC Healthcare, CAC Pharma & Bio, CAC Mid & Small, CAC All Tradable, EnterNext PEA-PME 150 and Next Biotech indexes.

Contact information

ERYTECH
Naomi Eichenbaum
Director Investor Relations
+33 4 78 74 44 38
+1-917-312-5151
naomi.eichenbaum@erytech.com
or
NewCap
Julien Perez
Investor relations
Nicolas Merigeau
Media relations
+33 1 44 71 98 52
erytech@newcap.eu

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Saudi Arabia’s Red Sea Project on Track13.12.2018 13:49Pressemelding

A delegation from the Red Sea Development Company, led by chief executive John Pagano, was received by King Salman bin Abdulaziz at Araqa Palace in Riyadh on Tuesday (December 11). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181213005406/en/ King Salman bin Abdulaziz of Saudi Arabia (centre) and Crown Prince Mohammed bin Salman with John Pagano, CEO of Red Sea Development Company. [Photo courtesy Saudi Press Agency (SPA)] Mr. Pagano made a visual presentation at the palace on the master plan of the Red Sea Project, underlining its economic and development goals and the project’s objective to become a global destination for luxury tourism. Crown Prince Mohammed bin Salman, Chairman of the company, was also present. Twenty-two islands on the Red Sea will be developed as part of the project that is expected to create an estimated 70,000 jobs. It will not just contribute SAR 22 billion to Saudi Arabia’s GDP, but play a major

GSMA’s Programme ‘Tech4Girls’ Wins 2018 Corporate Citizen of the Americas Award from the Organization of American States13.12.2018 13:00Pressemelding

The Trust for the Americas has selected GSMA as a winner of the 2018 Corporate Citizen of the Americas Award in the category ‘Technical Skills for the Future of Work’ for its program ‘Tech4Girls’. The award was presented by the Secretary General of the Organization of American States (OAS), Luis Almagro, at a ceremony held last week in Washington, D.C. Ana Tavares Lattibeaudiere, Head of North America, and Paula Ferrari, Regional Marketing Director for Latin America, received the award on behalf of the GSMA. Tech4Girls is part of the global GSMA’s Women4Tech programme, which focuses on reducing the persistent gender gap in the mobile industry. Women4Tech offers different touchpoints for women across their education and career journeys through dedicated initiatives, development and networking opportunities. Women4Tech supports the United Nations Sustainable Development Goals, in particular SDG 5: “Gender Equality.” Launched in March 2018 by GSMA North America, Tech4Girls delivers hands-

FLIR Systems Launches Three Cooled Neutrino Family Thermal Camera Cores13.12.2018 13:00Pressemelding

FLIR Systems, Inc. (NASDAQ: FLIR) today announced three Neutrino™ midwave infrared (MWIR) camera cores: the small, lightweight FLIR Neutrino LC and two FLIR Neutrino Performance series cores, the SX12 and QX. The latest models expand the FLIR Neutrino cooled camera core family for commercial, industrial, and defense original equipment manufacturers (OEM) and system integrators. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181213005036/en/ Next generation cooled FLIR Neutrino thermal camera cores: Neutrino LC (left) and Neutrino Performance Series (right). (Photo: Business Wire) The Neutrino LC is FLIR’s first High Operating Temperature (HOT) MWIR camera core and the first model in the SWaP+C (Size, Weight, Power, and Cost) series. As the smallest, lightest weight, and lowest power consuming Neutrino model available, the LC can be integrated with smaller drones and allow drone operators to fly longer. With HOT technology, N

TYAN Introduces Entry Server Platforms Optimized for the New Intel® Xeon® E-2100 Processors13.12.2018 13:00Pressemelding

TYAN®, an industry-leading server platform design manufacturer and a MiTAC Computing Technology Corporation subsidiary, is releasing a broad selection of new server motherboards and systems optimized for the new Intel® Xeon® E-2100 processors. The new lineup is designed to offer enhanced performance, advanced security, and reliability of cost-effective entry server solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181213005005/en/ TYAN's New Intel Xeon E-2100 Processor-based Platforms Increase Reliability and Security for Entry Servers. (Photo: Business Wire) “Small and medium-size businesses need to maintain their competitiveness by deploying a powerful server platform for performance, enhanced memory capabilities, and hardware-enhanced security,” said Danny Hsu, Vice President of MiTAC Computing Technology Corporation's TYAN Business Unit. “TYAN’s Intel® Xeon® E-2100 processor-based platforms are optimized for clou

Biomax Informatics launches the NeuroXM™ Brain Science Suite13.12.2018 12:57Pressemelding

Biomax Informatics AG announced the launch of its latest product, the NeuroXM™ Brain Science Suite, this week at the Biomax-ETRI Symposium on Cognitive Brain Informatics held in Planegg, Germany. Following a successful early-adaptor program, the company launched the NeuroXM suite of tools and features for working with multimodal high-dimensional brain data ready for clinical use. The award-winning NeuroXM Brain Science Suite lets brain scientists work interactively with high-dimensional multimodal brain data ranging from neuroimaging to genetics and transcriptomics. The suite includes a unified knowledge model for managing the abundant heterogeneous data available for the brain. It connects patient brain data to public knowledge in databases, atlases and ontologies for automatic annotation with methodological meta-information so that they become invaluable for clinical and scientific use. The NeuroXM suite supports every brain science task from standardizing preprocessing workflows to

Slice Insurance Cloud Services Now Available in the UK & EU13.12.2018 12:00Pressemelding

Slice Labs Inc., an award-winning on-demand insurance cloud platform provider, announced today the availability of Insurance Cloud Services (ICS) in the UK and EU. The first customer to use ICS in the UK is Legal & General with the launch of on-demand, pay-per-use homeshare cover. Insurance products available through the Slice ICS platform offer customers a rich, engaging, fully digital experience that is quick, and flexible. True to the company’s stated intention of extending global availability of ICS following a $20M USD Extended Series A, UK and EU insurers are now able to subscribe to ICS and launch on-demand insurance products customised to locale, language, and demographics. Cheryl Agius, CEO of Legal & General’s Insurance division, said “Legal & General is delighted to be working with Slice on the new on-demand product, a growing business in the US and now in the UK market.” European insurtech influencer Dr. Robin Kiera, CEO of DigitalScouting added, “Digital transformation lea